Bacterial lipopolysaccharides variably modulate in vitro biofilm formation of Candida species

Journal of Medical Microbiology

Volumn 59, Issue 10, 2010, Pages 1225-1234

  Bandara, H M H N ^a   Lam, O L T ^b   Watt, R M ^a   Jin, L J ^b   Samaranayake, L P ^a  

^a UNIVERSITY OF HONG KONG   (Hong Kong)

^b UNIVERSITY OF HONG KONG   (Hong Kong)

Author keywords

[No Author keywords available]

Indexed keywords

BACTERIUM LIPOPOLYSACCHARIDE; ENDOTOXIN; 2,3-BIS(2-METHOXY-4-NITRO-5-SULFOPHENYL)-5-((PHENYLAMINO)CARBONYL)-2H-TETRAZOLIUM HYDROXIDE; LIPOPOLYSACCHARIDE; TETRAZOLIUM;

ARTICLE; BIOFILM; CANDIDA; CANDIDA ALBICANS; CANDIDA DUBLINIENSIS; CANDIDA GLABRATA; CANDIDA KRUSEI; CANDIDA PARAPSILOSIS; CANDIDA TROPICALIS; CONFOCAL LASER MICROSCOPY; CONTROLLED STUDY; IN VITRO STUDY; KLEBSIELLA PNEUMONIAE; MICROBIAL ADHESION; MICROBIAL COLONIZATION; NONHUMAN; PRIORITY JOURNAL; PSEUDOMONAS; PSEUDOMONAS AERUGINOSA; QUALITATIVE ANALYSIS; QUANTITATIVE ANALYSIS; SALMONELLA; SALMONELLA TYPHIMURIUM; SCANNING ELECTRON MICROSCOPY; SERRATIA MARCESCENS; TIME; ANTIBIOSIS; CELL ADHESION; CELL WALL; CHEMISTRY; CONFOCAL MICROSCOPY; GRAM NEGATIVE BACTERIUM; GROWTH, DEVELOPMENT AND AGING; HUMAN; ISOLATION AND PURIFICATION; METABOLISM; MICROBIAL VIABILITY; OXIDATION REDUCTION REACTION; PHYSIOLOGY;

ANTIBIOSIS; BIOFILMS; CANDIDA; CELL ADHESION; CELL WALL; GRAM-NEGATIVE BACTERIA; HUMANS; LIPOPOLYSACCHARIDES; MICROBIAL VIABILITY; MICROSCOPY, CONFOCAL; OXIDATION-REDUCTION; TETRAZOLIUM SALTS; TIME FACTORS;

EID: 77957307594     PISSN: 00222615     EISSN: None     Source Type: Journal    
DOI: 10.1099/jmm.0.021832-0     Document Type: Article

References (42)

1. Akagawa, G., Abe, S. & Yamaguchi, H. (1995). Mortality of Candida albicans-infected mice is facilitated by superinfection of Escherichia coli or administration of its lipopolysaccharide. J Infect Dis 171, 1539-1544.
2. Aurell, C. A. & Wistrom, A. O. (1998). Critical aggregation concentrations of gram-negative bacterial lipopolysaccharides (LPS). Biochem Biophys Res Commun 253, 119-123.
3. Bandara, H. M., Yau, J. Y., Watt, R. M., Jin, L. J. & Samaranayake, L. P. (2009). Escherichia coli and its lipopolysaccharide modulate in vitro Candida biofilm formation. J Med Microbiol 58, 1623-1631.
4. Burd, R. S., Raymond, C. S. & Dunn, D. L. (1992). Endotoxin promotes synergistic lethality during concurrent Escherichia coli and Candida albicans infection. J Surg Res 52, 537-542.
5. Charles, P. E., Doise, J. M., Quenot, J. P., Aube, H., Dalle, F., Chavanet, P., Milesi, N., Aho, L. S., Portier, H. & Blettery, B. (2003). Candidemia in critically ill patients: difference of outcome between medical and surgical patients. Intensive Care Med 29, 2162-2169.
6. Eubanks, P. J., de Virgilio, C., Klein, S. & Bongard, F. (1993). Candida sepsis in surgical patients. Am J Surg 166, 617-619.
7. Hedderwick, S. A., Lyons, M. J., Liu, M., Vazquez, J. A. & Kauffman, C. A. (2000). Epidemiology of yeast colonization in the intensive care unit. Eur J Clin Microbiol Infect Dis 19, 663-670.
8. Henry-Stanley, M. J., Hess, D. J., Erickson, E. A., Garni, R. M. & Wells, C. L. (2003). Effect of lipopolysaccharide on virulence of intestinal Candida albicans. J Surg Res 113, 42-49.
9. Hess, D. J., Henry-Stanley, M. J., Bendel, C. M., Zhang, B., Johnson, M. A. & Wells, C. L. (2009). Escherichia coli and TNF-α modulate macrophage phagocytosis of Candida glabrata. J Surg Res 155, 217-224.
10. Jenkinson, H. F. & Douglas, L. J. (2002). Interactions between Candida species and bacteria in mixed infections. In Polymicrobial Diseases, pp. 357-373. Edited by K. A. Brogden & J. M. Guthmiller. Washington, DC: American Society for Microbiology.
11. Jin, Y., Samaranayake, L. P., Samaranayake, Y. & Yip, H. K. (2004). Biofilm formation of Candida albicans is variably affected by saliva and dietary sugars. Arch Oral Biol 49, 789-798.
12. Jin, Y., Zhang, T., Samaranayake, Y. H., Fang, H. H., Yip, H. K. & Samaranayake, L. P. (2005). The use of new probes and stains for improved assessment of cell viability and extracellular polymeric substances in Candida albicans biofilms. Mycopathologia 159, 353-360.
13. Klaerner, H. G., Uknis, M. E., Acton, R. D., Dahlberg, P. S., Carlone-Jambor, C. & Dunn, D. L. (1997). Candida albicans and Escherichia coli are synergistic pathogens during experimental microbial peritonitis. J Surg Res 70, 161-165.
14. Luchi, M. & Morrison, D. C. (2000). Comparable endotoxic properties of lipopolysaccharides are manifest in diverse clinical isolates of gram-negative bacteria. Infect Immun 68, 1899-1904.
15. Mah, T. F. & O'Toole, G. A. (2001). Mechanisms of biofilm resistance to antimicrobial agents. Trends Microbiol 9, 34-39.
16. Makin, S. A. & Beveridge, T. J. (1996). Pseudomonas aeruginosa PAO1 ceases to express serotype-specific lipopolysaccharide at 45 °C. J Bacteriol 178, 3350-3352.
17. McLean, R. J. C., Bates, C. L., Banes, M. B., McGowin, C. L. & Aron, G. M. (2004). Methods of studying biofilms. In Microbial Biofilms, pp. 279-413. Edited by M. Ghannoum & G. O'Toole. Washington, DC: American Society for Microbiology.
18. Michalek, S. M., Moore, R. N., McGhee, J. R., Rosenstreich, D. L. & Mergenhagen, S. E. (1980). The primary role of lymphoreticular cells in the mediation of host responses to bacterial endotoxin. J Infect Dis 141, 55-63.
19. Morrison, D. C. & Leive, L. (1975). Fractions of lipopolysaccharide from Escherichia coli O111 : B4 prepared by two extraction procedures. J Biol Chem 250, 2911-2919.
20. Morrison, D. C. & Ryan, J. L. (1987). Endotoxins and disease mechanisms. Annu Rev Med 38, 417-432.
21. Morrison, D. C., Betz, S. J. & Jacobs, D. M. (1976). Isolation of a lipid A bound polypeptide responsible for "LPS-initiated" mitogenesis of C3H/HeJ spleen cells. J Exp Med 144, 840-846.
22. Morrison, D. C., Vukajlovich, S. W., Ryan, J. L. & Levin, J. (1987). Structural requirements for gelation of the Limulus amebocyte lysate by endotoxin. Prog Clin Biol Res 231, 55-73.
23. Nobile, C. J. & Mitchell, A. P. (2007). Microbial biofilms: e pluribus unum. Curr Biol 17, R349-R353.
24. Odds, F. C. (1988). Candida and Candidosis, 2nd edn. London: Baillière Tindall.
25. O'Toole, G., Kaplan, H. B. & Kolter, R. (2000). Biofilm formation as microbial development. Annu Rev Microbiol 54, 49-79.
26. Palma, C., Cassone, A., Serbousek, D., Pearson, C. A. & Djeu, J. Y. (1992). Lactoferrin release and interleukin-1, interleukin-6, and tumor necrosis factor production by human polymorphonuclear cells stimulated by various lipopolysaccharides: relationship to growth inhibition of Candida albicans. Infect Immun 60, 4604-4611.
27. Pappas, P. G., Rex, J. H., Lee, J., Hamill, R. J., Larsen, R. A., Powderly, W., Kauffman, C. A., Hyslop, N., Mangino, J. E. & other authors (2003). A prospective observational study of candidemia: epidemiology, therapy, and influences on mortality in hospitalized adult and pediatric patients. Clin Infect Dis 37, 634-643.
28. Peres-Bota, D., Rodriguez-Villalobos, H., Dimopoulos, G., Melot, C. & Vincent, J. L. (2004). Potential risk factors for infection with Candida spp. in critically ill patients. Clin Microbiol Infect 10, 550-555.
29. Pfaller, M. A. (1996). Nosocomial candidiasis: emerging species, reservoirs, and modes of transmission. Clin Infect Dis 22, S89-S94.
30. Pittet, D. & Wenzel, R. P. (1995). Nosocomial bloodstream infections: secular trends in rates, mortality, and contribution to total hospital deaths. Arch Intern Med 155, 1177-1184.
31. Ramage, G., VandeWalle, K., Wickes, B. L. & López-Ribot, J. L. (2001). Characteristics of biofilm formation by Candida albicans. Rev Iberoam Micol 18, 163-170.
32. Rangel-Frausto, M. S. (1999). The epidemiology of bacterial sepsis. Infect Dis Clin North Am 13, 299-312.
33. Rangel-Frausto, M. S., Wiblin, T., Blumberg, H. M., Saiman, L., Patterson, J., Rinaldi, M., Pfaller, M., Edwards, J. E., Jr, Jarvis, W. & other authors (1999). National epidemiology of mycoses survey (NEMIS): variations in rates of bloodstream infections due to Candida species in seven surgical intensive care units and six neonatal intensive care units. Clin Infect Dis 29, 253-258.
34. Richards, M. J., Edwards, J. R., Culver, D. H. & Gaynes, R. P. (1999). Nosocomial infections in medical intensive care units in the United States. Crit Care Med 27, 887-892.
35. Rietschel, E. T., Schade, U., Jensen, M., Wollenweber, H. W., Luderitz, O. & Greisman, S. G. (1982). Bacterial endotoxins: chemical structure, biological activity and role in septicaemia. Scand J Infect Dis Suppl 31, 8-21.
36. Sabra, W., Lunsdorf, H. & Zeng, A. P. (2003). Alterations in the formation of lipopolysaccharide and membrane vesicles on the surface of Pseudomonas aeruginosa PAO1 under oxygen stress conditions. Microbiology 149, 2789-2795.
37. Samaranayake, L. P. & MacFarlane, T. W. (1990). Oral Candidosis. London: Wright.
38. Snydman, D. R. (2003). Shifting patterns in the epidemiology of nosocomial Candida infections. Chest 123, 500S-503S.
39. Tracey, K. J., Fong, Y., Hesse, D. G., Manogue, K. R., Lee, A. T., Kuo, G. C., Lowry, S. F. & Cerami, A. (1987). Anti-cachectin/TNF monoclonal antibodies prevent septic shock during lethal bacteraemia. Nature 330, 662-664.
40. Vukajlovich, S. W. & Morrison, D. C. (1985). Activation of murine spleen cells by lipid A: negative modulation of lipid A mitogenic activity by O-antigen polysaccharide. J Immunol 135, 2546-2550.
41. Wisplinghoff, H., Bischoff, T., Tallent, S. M., Seifert, H., Wenzel, R. P. & Edmond, M. B. (2004). Nosocomial bloodstream infections in US hospitals: analysis of 24,179 cases from a prospective nationwide surveillance study. Clin Infect Dis 39, 309-317.
42. Young, L. (1985). Gram negative sepsis. In Principles and Practice of Infectious Diseases, pp. 452-476. Edited by G. L. Mandell, R. G. Douglas & J. E. Bennet. New York: Wiley.